MedPath

Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)

Not Applicable
Completed
Conditions
Anemia
Malaria, Falciparum
Registration Number
NCT02448745
Lead Sponsor
The Mentor Initiative
Brief Summary

A cluster-randomized control trial will study the effect of insecticide-treated wall lining on malaria transmission in Bomi County, Liberia. Half of the villages enrolled in the study will receive insecticide-treated wall lining covering their walls and ceilings in addition to long-lasting insecticidal nets, while the other half will be protected by existing long-lasting insecticidal nets.

Detailed Description

Long-lasting insecticidal nets (LLINs) are the established vector control product for malaria control. In Bomi County Liberia, LLINs have been distributed but malaria prevalence in children under 5 remains high, with prevalence in study villages found to be 42% in April 2014. The major malaria vector species are resistant to pyrethroid insecticides approved for use in LLINs, and new control measures with non-pyrethroid active ingredients may protect the population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6317
Inclusion Criteria
  • Child resides in village
  • Child presents with parent or guardian
Exclusion Criteria
  • Child or guardian has history of Ebola exposure
  • Child has 3 symptoms of Ebola

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Malaria Prevalence6 months

Tested by mRDT and PCR

Secondary Outcome Measures
NameTimeMethod
Mosquito biting rate.2 months

Mosquitoes trapped indoors and outdoors using light traps and exit traps.

Hemoglobin6 months

Hemoglobin measured by Hemocue 301

Fever6 months

Number of participants with Fever, defined as tympanic temperature above 37.5C

Trial Locations

Locations (1)

Bomi County Health Team

🇱🇷

Tubmanburg, Bomi County, Liberia

Bomi County Health Team
🇱🇷Tubmanburg, Bomi County, Liberia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.